Literature DB >> 19236948

Epilepsy and hormones: a critical review.

Gerhard Luef1, Markus Rauchenzauner.   

Abstract

Especially during growth, puberty, and menopause, profound changes including maturation of the growth hormone, sex steroid, and thyroid axes, as well as alterations in lipid homeostasis, cardiac integrity, and other enzyme systems, occur physiologically. With epilepsy, however, things are often changing, and there may be a complicated interplay between hormones, epilepsy, and antiepileptic drugs (AEDs). On the one hand, epilepsy itself possibly elicits diverse effects on different enzyme systems including sex steroids, the neuro-cardio-endocrine axis, and bone health. On the other hand, different AEDs are known to induce neuroendocrine changes (e.g., lipid metabolism) that may have deleterious consequences on health and well-being later in life. It is important for physicians and epileptologists to have in mind and to consider the endocrine effects induced by epilepsy itself or by a certain AED when starting antiepileptic therapy, especially when it is expected that long-term treatment will be necessary.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19236948     DOI: 10.1016/j.yebeh.2009.02.022

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  7 in total

1.  The antiepileptic effect of sodium valproate during different phases of the estrous cycle in PTZ-induced seizures in rats.

Authors:  Jahangir Kaboutari; Morteza Zendehdel; Saeed Habibian; Mahmood Azimi; Mohammad Shaker; Behnaz Karimi
Journal:  J Physiol Biochem       Date:  2011-11-11       Impact factor: 4.158

2.  GABAB Receptor Blockade Prevents Antiepileptic Action of Ghrelin in the Rat Hippocampus.

Authors:  Zohreh Ataie; Shirin Babri; Mina Ghahramanian Golzar; Hadi Ebrahimi; Fariba Mirzaie; Gisou Mohaddes
Journal:  Adv Pharm Bull       Date:  2013-08-20

3.  Impact of rapamycin on status epilepticus induced hippocampal pathology and weight gain.

Authors:  Michael S Hester; Bethany E Hosford; Victor R Santos; Shatrunjai P Singh; Isaiah J Rolle; Candi L LaSarge; John P Liska; Norberto Garcia-Cairasco; Steve C Danzer
Journal:  Exp Neurol       Date:  2016-03-17       Impact factor: 5.330

Review 4.  Preclinical evidence of ghrelin as a therapeutic target in epilepsy.

Authors:  Tongtong Ge; Wei Yang; Jie Fan; Bingjin Li
Journal:  Oncotarget       Date:  2017-06-02

5.  Urinary volatile metabolites of amygdala-kindled mice reveal novel biomarkers associated with temporal lobe epilepsy.

Authors:  Akiko Fujita; Manami Ota; Keiko Kato
Journal:  Sci Rep       Date:  2019-07-22       Impact factor: 4.379

6.  The Impact of Antiepileptic Drugs on Thyroid Function in Children with Epilepsy: New Versus Old.

Authors:  Hatem Hamed Elshorbagy; Naglaa Fathy Barseem; Hany Abdelaziz Suliman; Eman Talaat; Ashraf Hamed AlSHOKARY; Waleed Elsayed Abdelghani; Sameh Elsayed Abdulsamea; Yehia Hamed Abdel Maksoud; Sanaa Mohammed Azab; Akram Elshafey Elsadek; Dalia Mohamed Nour El Din
Journal:  Iran J Child Neurol       Date:  2020

Review 7.  Anti-apoptotic Actions of Allopregnanolone and Ganaxolone Mediated Through Membrane Progesterone Receptors (PAQRs) in Neuronal Cells.

Authors:  Peter Thomas; Yefei Pang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-24       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.